Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Plant-based diets may help patients with diabetes, heart disease live longer
Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago.
Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’
Researchers still think patients should receive an injectable version of semaglutide when possible, but new data out of ACC.25 confirm that an oral formulation of the drug is associated with significant benefits.
FDA sees promise in new AI model for heart attack detection
Powerful Medical's advanced algorithm was designed to detect STEMI and STEMI-equivalent patterns in a patient’s ECG results.
Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks
When patients require subsequent noncardiac surgery after a major heart operation, waiting at least 100 days is one way to limit the risk of an adverse event. Read the full analysis in JACC: Advances.
Abbott makes IVL move as FDA approves new clinical trial
Abbott has received an investigational device exemption from the FDA for a new clinical trial evaluating the safety and effectiveness of using its coronary IVL technology. The trial is expected to enroll up to 335 U.S. patients.

Cardiologist Martha Gulati, MD, who specializes in both preventive cardiology and cardiovascular disease in women, has been named the Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research at Cedars-Sinai in Los Angeles.

Cardiologist Martha Gulati named chair of women’s cardiovascular medicine and research at Cedars-Sinai

Gulati, an award-winning cardiologist and author, first joined Cedars-Sinai in 2022. She is also the president of the American Society for Preventive Cardiology.

$The Neovasc Reducer System is designed to treat the symptoms of refractory angina by altering a patient's blood flow.$

Shockwave Medical to acquire medical device company for $100M

Shockwave Medical's decision to acquire Neovasc is based largely on the potential of the Neovasc Reducer System, a solution designed to treat the symptoms of refractory angina by altering a patient's blood flow.

Patients with especially high blood pressure may want to limit how much coffee they drink

Researchers explored nearly 20 years of data from more than 18,000 patients, sharing their findings in the Journal of the American Heart Association.

FDA announces recall of intra-aortic balloon pumps due to risk of cardiac arrest, stroke or death

The recall includes more than 2,000 devices distributed to customers in 2022. There have been 241 complaints, and 135 reported pump stops, related to this issue.

Cardiovascular disease still the No. 1 cause of death in the world

A new global report, based on data from 204 different countries and territories, has been published in full in the Journal of the American College of Cardiology.

DASH diet reduces long-term risk of heart disease

Following the DASH diet is associated with key health benefits, according to a new analysis published in the American Journal of Cardiology.

An inflated intra-aortic balloon pump (IABP) with the Maquet Cardiosave system.

Supply chain problems: FDA warns of new shortage of intra-aortic balloon pumps, catheters and spare parts

Getinge has provided a detailed breakdown of the shortage, stating that it is not yet clear when it may be over. The FDA said it will keep a close eye on the situation and provide updates when possible.

New AI model calculates risk of heart attack or stroke using a single X-ray

“This type of screening could be used to identify individuals who would benefit from statin medication but are currently untreated," one specialist said. The full analysis will be presented at RSNA 2022 in Chicago.

Acute Coronary Syndromes

Plant-based diets may help patients with diabetes, heart disease live longer

Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’

FDA sees promise in new AI model for heart attack detection

Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks

Abbott makes IVL move as FDA approves new clinical trial